ALPEX TRADING LTD
Company number 14070871 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ALPEX TRADING LTD - Analysis Report
Company Number: 14070871
Analysis Date: 2025-07-29 15:41 UTC
Financial Health Assessment for ALPEX TRADING LTD (as of 30 April 2024)
1. Financial Health Score: D
Explanation:
The company's financial health reveals early warning signs of distress, particularly in liquidity and equity erosion. While the firm remains operational with positive shareholders' funds, a sharp decline from £100 to £10 within one year, combined with increasing current liabilities, suggests a fragile financial condition. The score "D" reflects concerns for sustainability without immediate intervention.
2. Key Vital Signs
| Metric | 2024 (£) | 2023 (£) | 2022 (£) | Interpretation |
|---|---|---|---|---|
| Cash in Hand | 100 | 100 | 100 | Static cash balance; very low absolute cash amount |
| Current Liabilities | 90 | 0 | 0 | Emerging short-term obligations; risk of cash flow strain |
| Net Current Assets (Working Capital) | 10 | 100 | 100 | Working capital severely depleted; liquidity tightening |
| Total Assets Less Current Liabilities | 10 | 100 | 100 | Asset base net of current debts sharply reduced |
| Shareholders' Funds (Equity) | 10 | 100 | 100 | Equity eroded by 90%; indicates losses or withdrawals |
| Employees | 0 | 0 | 0 | No employees; minimal operational scale |
Interpretation of Vital Signs:
- Liquidity: The company's cash is static but extremely low (£100). The emergence of current liabilities (£90) means cash available barely covers short-term debts, implying a "symptom of distress" in liquidity.
- Working Capital: Net current assets dropped from £100 to £10, indicating a tight working capital position, which is precarious for day-to-day operations.
- Equity: Shareholders' funds dropped drastically from £100 to £10, signaling accumulated losses or capital withdrawals reducing the financial "immune system" of the company.
- Operational Scale: No employees reported, which may limit operational capability, but could also reflect a very small or start-up business model.
3. Diagnosis
The company's financial "vital signs" suggest it is experiencing early-stage financial strain. The sharp decline in equity and working capital, alongside the appearance of current liabilities, indicates the business may be facing operational challenges such as increased payables or short-term obligations without commensurate asset growth or profitability.
The static cash position, while not deteriorating, is at a very low absolute level (£100), insufficient as a buffer against unexpected expenses or downturns. The absence of employees could mean limited operational activity or reliance on directors/owners for management.
Overall, the company appears to be in a "fragile health" state. The "symptoms" point to potential cash flow pressures and weakened equity base that, if not addressed, could worsen and lead to financial distress.
4. Recommendations
To improve financial wellness and avoid progression to more serious "illness," the company should consider:
Enhance Liquidity: Seek to increase cash reserves through improved cash collection, cost control, or capital injection. A healthy cash flow is critical to meet current liabilities promptly.
Manage Payables: Negotiate extended payment terms with creditors or reduce short-term liabilities to ease immediate cash demands.
Review Capital Structure: Consider whether additional equity funding or shareholder loans are needed to restore the equity base and strengthen financial resilience.
Operational Review: Assess business model and scale—if no employees are involved, ensure key operational tasks are covered effectively to support revenue generation.
Financial Monitoring: Implement regular financial reviews focusing on liquidity ratios, working capital management, and profitability to detect issues early.
Strategic Planning: Develop a clear plan to grow the asset base and revenues, reducing reliance on short-term financing and improving long-term stability.
Medical Analogy Summary
Think of ALPEX TRADING LTD as a patient with a weakened immune system (equity) and signs of dehydration (low cash). The body's (business's) vital organs are functioning but under strain. Without replenishing fluids (cash) and nutrients (capital), the patient's condition could deteriorate quickly. Early intervention with supportive care and lifestyle changes (financial management and strategic planning) is essential for recovery and long-term health.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.